| Meijer Pharmacy #272 | |
| 1676 Westpark Dr, Bowling Green, Kentucky 42104 | |
| (270) 495-6710 |
| Name | Meijer Pharmacy #272 |
|---|---|
| Organization Name | Meijer Great Lakes Limited Partnership |
| Location | 1676 Westpark Dr, Bowling Green, Kentucky 42104 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (270) 495-6710 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Johns Hopkins researchers report that a type of biodegradable, lab-engineered nanoparticle they fashioned can successfully deliver a "suicide gene" to pediatric brain tumor cells implanted in the brains of mice.
A smoking-prevention strategy that targets black fourth-graders and their parents is under study in urban and rural Georgia.
Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.
An enzyme that normally helps break down stored fats goes into overdrive in some cancer cells, making them more malignant, according to new findings by a team at The Scripps Research Institute.
VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.
› Verified 5 days ago
| NPI Number | 1346650850 |
| Organization Name | MEIJER GREAT LAKES LIMITED PARTNERSHIP |
| Doing Business As | MEIJER PHARMACY #272 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1676 Westpark Dr., Bowling Green, KY 42104 |
| Phone Number | 270-495-6710 |
News Archive
Johns Hopkins researchers report that a type of biodegradable, lab-engineered nanoparticle they fashioned can successfully deliver a "suicide gene" to pediatric brain tumor cells implanted in the brains of mice.
A smoking-prevention strategy that targets black fourth-graders and their parents is under study in urban and rural Georgia.
Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.
An enzyme that normally helps break down stored fats goes into overdrive in some cancer cells, making them more malignant, according to new findings by a team at The Scripps Research Institute.
VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.
› Verified 5 days ago
| NPI Number | 1902378813 |
| Organization Name | MEIJER GREAT LAKES LIMITED PARTNERSHIP |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1676 Westpark Dr, Bowling Green, KY 42104 |
| Phone Number | 270-495-6710 |
News Archive
Johns Hopkins researchers report that a type of biodegradable, lab-engineered nanoparticle they fashioned can successfully deliver a "suicide gene" to pediatric brain tumor cells implanted in the brains of mice.
A smoking-prevention strategy that targets black fourth-graders and their parents is under study in urban and rural Georgia.
Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.
An enzyme that normally helps break down stored fats goes into overdrive in some cancer cells, making them more malignant, according to new findings by a team at The Scripps Research Institute.
VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.
› Verified 5 days ago
News Archive
Johns Hopkins researchers report that a type of biodegradable, lab-engineered nanoparticle they fashioned can successfully deliver a "suicide gene" to pediatric brain tumor cells implanted in the brains of mice.
A smoking-prevention strategy that targets black fourth-graders and their parents is under study in urban and rural Georgia.
Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.
An enzyme that normally helps break down stored fats goes into overdrive in some cancer cells, making them more malignant, according to new findings by a team at The Scripps Research Institute.
VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.
› Verified 5 days ago
Medequip Type: Durable Medical Equipment & Medical Supplies Supplier Location: 825 2nd Ave East, Bowling Green, Kentucky 42101 Phone: (270) 780-2655 | |
Tomorrow's Woman Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1623 Scottsville Rd, Bowling Green, Kentucky 42104 Phone: (270) 781-5171 | |
Vision Source Of Bowling Green Type: Medicare Supplier Location: 335 New Towne Rd, Bowling Green, Kentucky 42103 Phone: (270) 842-0383 | |
C.d.s. #10 Pharmacy Llc Type: Long Term Care Pharmacy Location: 1308 Ashley Circle, Bowling Green, Kentucky 42104 Phone: (270) 781-5661 | |
Springhill Pharmacy Type: Pharmacy Location: 2305 Russellville Rd, Bowling Green, Kentucky 42101 Phone: (270) 796-3909 |